M&G »

Intra Cellular Therapies shares owned by M&G

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by M&G from 13F filings

Historical chart of M&G investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by M&G consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by M&G

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.1M 124k 73.00

More positions owned by M&G

Ferguson Enterprises Common Stock New (FERG)
Interdigital Note 3.500% 6/0 (Principal)
Diversified Energy Company P Shs New (DEC)
Burford Cap Ord Shs (BUR)
Microsoft Corporation (MSFT)
Amcor Ord (AMCR)
Broadcom (AVGO)
Methanex Corp (MEOH)
Bristol Myers Squibb (BMY)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Nextera Energy (NEE)
V.F. Corporation (VFC)
UnitedHealth (UNH)
CRH Ord (CRH)

View all positions for M&G

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Suvretta Capital Management
Deep Track Capital

View all funds holding Intra Cellular Therapies